Accuracy of axillary ultrasound in preoperative nodal staging of breast cancer - size of metastases as limiting factor

SpringerPlus

Volumn 2, Issue 1, 2013, Pages 1-9

  Stachs, Angrit ^a   Göde, Katja ^a   Hartmann, Steffi ^a   Stengel, Bernd ^b   Nierling, Ulrike ^a   Dieterich, Max ^a   Reimer, Toralf ^a   Gerber, Bernd ^a  

^a UNIVERSITY OF ROSTOCK   (Germany)

^b Institute for Pathology Pathology   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84887176045     PISSN: None     EISSN: 21931801     Source Type: Journal    
DOI: 10.1186/2193-1801-2-350     Document Type: Review

References (26)

1. Alvarez S, Anorbe E, Alcorta P, Lopez F, Alonso I, Cortes J (2006) Role of sonography in the diagnosis of axillary lymph node metastases in breast cancer: a systematic review. AJR 186:1342-1348. doi:10.2214/AJR.05.0936.
2. Bevilacqua JL, Kattan MW, Fey JV, Cody HS 3rd, Borgen PI, Van Zee KJ (2007) Doctor, what are my chances of having a positive sentinel node? A validated nomogram for risk estimation. J Clin Oncol 25(24):3670-3679.
3. Choi YJ, Ko EY, Han BK, Shin JH, Kang SS, Hahn SY (2009) High resolution ultrasonographic features of axillary lymph node metastasis in patients with breast cancer. Breast 18:119-122.
4. Cools-Lartigue J, Sinclair A, Trabulsi N, Meguerditchian A, Nesurolle B, Fuhrer R, Meterissian S (2013) Preoperative axillary ultrasound and fine-needle aspiration biopsy in the diagnosis of axillary metastases in patients with breast cancer: predictors of accuracy and future implications. Ann Surg Oncol 20(3):819-827. doi:10.1245/s10434-012-2609-7.
5. Deurloo EE, Tanis PJ, Gilhuijs KG, Muller SH, Kröger R, Peterse JL, Rutgers EJ, Valdés Olmos R, Schultze Kool LJ (2003) Reduction in the number of sentinel lymph node procedures by preoperative ultrasonography of the axilla in breast cancer. Eur J Cancer 39(8):1068-1073.
6. Engel J, Lebeau A, Sauer H, Hölzel D (2006) Are we wasting our time with the sentinel technique? Fifteen reasons to stop axilla dissection Breast 15(3):452-455.
7. Fisher B, Jeong JH, Anderson S, Bryant J, Fisher ER, Wolmark N et al (2002) Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation. N Engl J Med 347(8):567-575.
8. Galimberti V, Cole BF, Zurrida S, Viale G, Luini A, Veronesi P, Baratella P, Chifu C, Sargenti M, Intra M, Gentilini O, Mastropasqua MG, Mazzarol G, Massarut S, Garbay JR, Zgajnar J, Galatius H, Recalcati A, Littlejohn D, Bamert M, Colleoni M, Price KN, Regan MM, Goldhirsch A, Coates AS, Gelber RD, Veronesi U (2013) Axillary dissection versus no axillary dissection in patients with senitnel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial. Lancet Oncol 14:297-305.
9. Gentilini O, Veronesi U (2012) 2012) Abondong sentinel lymph node biopsy in early breast cancer? A new trial in progress at the European Institute of Oncology of Milan (SOUND: Sentinel node vs. Observation after axillary ultrasound. Breast 21(5):678-681. doi:10.1016/j.breast.2012.06.013.
10. Gerber B, Heintze K, Stubert J, Dieterich M, Hartmann S, Stachs A, Reimer T (2011) Axillary lymph node dissection in early-stage invasive breast cancer: is it still standard today? Breast Cancer Res Treat 128(3):613-624. doi:10.1007/s10549-011-1532-0.
11. Giuliano AE, Hunt KK, Ballman KV, Beitsch PD, Whitworth PW, Blumencranz PW, Leitch AM, Saha S, McCall LM, Morrow M (2011) Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA 305(6):569-575. doi:10.1001/jama.2011.90.
12. Group IBCS, Rudenstam CM, Zahrieh D, Forbes JF, Crivellari D, Holmberg SB, Rey P, Dent D, Campbell I, Bernhard J, Price KN, Castiglione-Gertsch M, Goldhirsch A, Gelber RD, Coates AS (2006) Randomized trial comparing axillary clearance versus no axillary clearance in older patients with breast cancer: first results of International Breast Cancer Study Group Trial 10-93. J Clin Oncol 24(3):337-344.
13. Houssami N, Ciatto S, Turner RM, Cody HS, Macaskill P (2011) Preoperative ultrasound-guided needle biopsy of axillary nodes in invasive breast cancer. Ann Surg 254:243-251. doi:10.1097/SLA.0b013e31.
14. Klar M, Foeldi M, Markert S, Gitsch G, Stickeler E, Watermann D (2009) Good prediction of the likelihood for sentinel lymph node metastasis by using the MSKCC nomogram in a german breast cancer population. Ann Surg Oncol 16(5):1136-1142. doi:10.1245/s10434-009-0399-3.
15. Krag DN, Anderson SJ, Julian TB, Brown AM, Harlow SP, Ashikaga T, Weaver DL, Miller BJ, Jalovec LM, Frazier TG, Noyes RD, Robidoux A, Scarth HM, Mammolito DM, McCready DR, Mamounas EP, Costantino JP, Wolmark N, National Surgical Adjuvant Breast and Bowel Project (2007) Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymphnode dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial. Lancet Oncol 8(10):881-888.
16. Krag DN, Anderson SJ, Julian TB, Brown AM, Harlow SP, Costantino JP, Ashikaga T, Weaver DL, Mamounas EP, Jalovec LM, Frazier TG, Noyes RD, Robidoux A, Scarth HM, Wolmark N (2010) Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial. Lancet Oncol 11(10):927-933. doi:10.1016/S1470-2045(10)70207-2.
17. Leenders MWH, Broeders M, Croese C, Richir MC, Go HLS, Meijer S, langenhorst BLAM, Schreurs WH (2012) Ultrasound and fine needle aspiration cytology of axillary lymph nodes in breast cancer. To do or not to do? Breast 21:578-583.
18. Mainiero MB, Cinelli CM, Koelliker SL, Graves TA, Chung MA (2010) Axillary ultrasound and fine-needle aspiration in the preoperative evaluation of the breast cancer patient: an algorithm based on tumor size and lymph node appearance. AJR 195:1261-1267.
19. Martelli G, Boracchi P, De Palo M, Pilotti S, Oriana S, Zucali R, Daidone MG, De Palo G (2005) A randomized trial comparing axillary dissection to no axillary dissection in older patients with T1N0 breast cancer: results after 5 years of follow-up. Ann Surg 242(1):1-6.
20. Mortellaro VE, Marshall J, Singer L, Hochwald SN, Chang M, Copeland EM, Grobmyer SR (2009) Magnetic resonance imaging for axillary staging in patients with breast cancer. J Magn Reson Imaging 30(2):309-312. doi:10.1002/jmri.21802.
21. Peare R, Staff RT, Heys SD (2010) The use of FDG-PETin assessing axillary lymph node status in breast cancer: a systematic review and meta-analysis of the literature. Breast Cancer Res Treat 123(1):281-290. doi:10.1007/s10549-010-0771-9.
22. Ueda S, Tsuda H, Asakawa H, Omata J, Fukatsu K, Kondo N, Kondo T, Hama Y, Tamura K, Ishida J, Abe Y, Mochizuki H (2008) Utility of 18F-fluorodeoxyglucose emission tomography/computed tomography (18F-FDG-PET/CT) in combination with ultrasonography for axillary staging in primary breast cancer. BMC Cancer 8:165. doi:10.1186/1471-2407-8-165.
23. Valente SA, Levine GM, Silverstein MJ, Rayhanabad JA, Weng-Grumley JG, Ji L, Holmes DR, Sposto R, Sener SF (2012) Accuracy of predicting axillary lymph node positivity by physical examination, mammography, ultrasonography and magnetic resonance imaging. Ann Surg Oncol 19:1825-1830.
24. Veronesi U, Paganelli G, Viale G, Luini A, Zurrida S, Galimberti V, Intra M, Veronesi P, Robertson C, Maisonneuve P, Renne G, De Cicco C, De Lucia F, Gennari R (2003) A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med 349(6):546-553.
25. Veronesi U, Galimberti V, Paganelli G, Maisonneuve P, Viale G, Orecchia R, Luini A, Intra M, Veronesi P, Caldarella P, Renne G, Rotmensz N, Sangalli C, De Brito LL, Tullii M, Zurrida S (2009) Axillary metastases in breast cancer patients with negative sentinel nodes: a follow-up of 3548 cases. Eur J Cancer 45(8):1381-1388. doi:10.1016/j.ejca.2008.11.041.
26. Viale G, Zurrida S, Maiorano E, Mazzarol G, Pruneri G, Paganelli G, Maisonneuve P, Veronesi U (2005) Predicting the status of axillary sentinel lymph nodes in 4351 patients with invasive breast carcinoma treated in a single institution. Cancer 103(3):492-500.